Analyst firms · H.C. Wainwright · TARO

H.C. Wainwright TARO price target and rating history

Taro Pharmaceutical Industries Ltd. (TARO) · Health Care

H.C. Wainwright rates Taro Pharmaceutical Industries Ltd. (TARO) Neutral with a $43 price target, as of its latest action on Jan 18, 2024. It has published 4 rating actions on TARO since July 2021, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$43
Median target, all firms
Too few
Actions on TARO
4

H.C. Wainwright price target on TARO

$82$63$4320222023202420252026
H.C. Wainwright price target on TARO, each point a stated target, July 2021 to January 2024.

Every H.C. Wainwright rating on TARO

Questions about H.C. Wainwright and TARO

What is H.C. Wainwright's price target for TARO?
H.C. Wainwright's latest stated price target for Taro Pharmaceutical Industries Ltd. (TARO) is $43, from its action on Jan 18, 2024.
What is H.C. Wainwright's rating on TARO?
H.C. Wainwright rates TARO Neutral, a neutral rating, as of Jan 18, 2024.
When did H.C. Wainwright last change its view on TARO?
On Jan 18, 2024, H.C. Wainwright downgrades to Neutral from Buy, price target $43.

All H.C. Wainwright ratingsTARO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.